Cagrilintide is a cutting-edge long-acting amylin analogue developed by Novo Nordisk This dual amylin and calcitonin receptor agonist offers a novel mechanism of action for weight management, providing researchers with a potent tool for metabolic health studies.
🚀 Key Benefits
*Dual Receptor Activation: Simultaneously targets amylin and calcitonin receptors to regulate appetite, enhance satiety, and modulate glucose metabolism.
*Clinically Proven Efficacy: Clinical studies have demonstrated that Cagrilintide leads to clinically significant, dose-dependent weight loss, with greater reductions observed at higher doses.
*Enhanced Metabolic Health: Treatment with Cagrilintide has been associated with significant reductions in body weight and improved metabolic parameters.
*Cost-Effective Research Tool: The 10mg vial offers a more affordable option for extended research protocols, reducing the cost per milligram compared to higher doses.
🧪 Composition
*Active Ingredient: Cagrilintide
*Concentration: 10mg per vial.
*Form: Lyophilized peptide powder
📦 Usage & Storage
Intended Use: For research purposes only
Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.
🛒 Order your 5mg Cagrilintide today for £300.00
